ClinicalTrials.govpublic full text
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
triple negative breast cancer, endometrial cancer, solid tumor, unspecified, adult, colorectal cancer, breast cancer, triple negative, her2-, hr-, er-, pr-, her2 negative, hr negative
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 810907
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.